about
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyCharacterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from IndiaMolecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansionHuman neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infectionDissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United StatesCharacterization of plasmids in extensively drug-resistant acinetobacter strains isolated in India and Pakistan.Random insertion and gene disruption via transposon mutagenesis of Ureaplasma parvum using a mini-transposon plasmidExtensively drug-resistant New Delhi metallo-β-lactamase-encoding bacteria in the environment, Dhaka, Bangladesh, 2012.Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d' beta-lactamase in Pseudomonas aeruginosa.Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom.Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya.Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program.ISCR elements: novel gene-capturing systems of the 21st century?Unconventional Human T Cells Accumulate at the Site of Infection in Response to Microbial Ligands and Induce Local Tissue Remodeling.Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase.Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program.The Future of Peritoneal Dialysis in a Moving Landscape of Bacterial Resistance.Biochemical characterization of the acquired metallo-beta-lactamase SPM-1 from Pseudomonas aeruginosa.Horizontal transfer of the blaNDM-1 gene to Pseudomonas aeruginosa and Acinetobacter baumannii in biofilms.First detection of extended-spectrum cephalosporin- and fluoroquinolone-resistant Escherichia coli in Australian food-producing animals.World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production.Genetic & virulence profiling of ESBL-positive E. coli from nosocomial & veterinary sources.Plasmid carriage of bla NDM-1 in clinical Acinetobacter baumannii isolates from India.Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTCo-existence of blaNDM-1 and blaKPC-2 in clinical isolates of Klebsiella pneumoniae from Pakistan.blaVIM-2-harboring integrons isolated in India, Russia, and the United States arise from an ancestral class 1 integron predating the formation of the 3' conserved sequence.Genetic characterization and emergence of the metallo-β-lactamase GIM-1 in Pseudomonas spp. and Enterobacteriaceae during a long-term outbreak.ISCR elements are key players in IncA/C plasmid evolution.Molecular analysis of the sequences surrounding blaOXA-45 reveals acquisition of this gene by Pseudomonas aeruginosa via a novel ISCR element, ISCR5A promising target for treatment of multidrug-resistant bacterial infections.blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program.First report of the metallo-beta-lactamase SPM-1 in Europe.Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006.Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001).Genetic characterization of a novel metallo-beta-lactamase gene, blaIMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme.Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program.The first metallo-beta-lactamase identified in norway is associated with a TniC-like transposon in a Pseudomonas aeruginosa isolate of sequence type 233 imported from Ghana.Salmonella bloodstream infections: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002).
P50
Q24617818-AF9730C7-E938-431B-83F4-B866305EAF18Q24647709-675C156D-0888-495E-BD9C-2966282BB67AQ33559180-0477230F-271F-4635-8ABF-EC30832FC4F2Q33904052-967C8B18-FB0B-495A-9035-0F786D70B3B2Q34177006-3DF4CF35-BA36-4E04-A716-42A305E2F66FQ35005911-A0826ED3-EBA1-4D76-8083-0343392FD012Q35106034-1B252EE3-E134-4E4E-BA44-7042B050DD0DQ35668406-95AB6824-C0D1-4A7E-8C08-D8B05CB7E557Q35673464-2F39B9BE-977C-47BB-875D-8245D139CA14Q35685004-37C53690-A4AF-4EA2-B968-91CB7DAA9003Q35941398-3570580F-C7D3-4400-96C0-567BC84FB10DQ35941520-D6E05D3F-0911-4804-A518-AC6292BB19DCQ36201243-71F42FDF-0D0F-43A5-97DA-2AC3ABDEDBFBQ36499667-15A2097C-F5FD-4875-A02F-E9DF2E56B2ECQ37229095-F2BF7C0C-ECBC-41DF-8A11-4FF2F5F49455Q37624541-EB969070-C0C5-4B96-A960-B25047FC103EQ37624751-9A6E9A30-0D78-45B3-B196-B7CF84E6EEE8Q38737475-0E82C66D-77C6-4107-B6A6-6D2D96C5ED8AQ39740599-5E2E2317-A7EB-40A2-AF87-4CC9718CE62CQ40282092-F006065C-9DB1-4ACD-9980-E20AE0F9E09DQ40452589-62FE7166-9FC1-4615-A445-60156032269FQ40605997-81CE2581-9D33-47BD-B402-BF8248F9ABA6Q40739784-CF86E1BC-348E-44DD-9DAD-7AD28A564727Q41081493-DB3EF3A4-2F51-4148-94F2-0A122F958C33Q41454153-B8AF445B-1E15-42A1-8E69-6B8543935BF6Q41656823-5BBA1199-CB0F-4DB8-8825-51F9CCAA7E2AQ41826663-56123392-DE75-47FE-9E52-E3C272706456Q42041697-A5964457-BBAD-40D0-9BC9-B1EE7D16429CQ42577194-07E5CC2D-6F53-48EB-B213-2361B19ED539Q42605593-A61AAF7F-0B01-4482-ACF9-54B6C5923F75Q42772473-0E5BBF1D-A617-41FF-B9B3-6B801C53D0F6Q42912495-5442B855-ADC5-4B11-B4D8-28F816ABC002Q42947072-D4C89710-1478-4A9B-903E-A87C65B46F42Q43168732-259A6A9D-44A4-4E22-9F94-EAD486B7A77CQ43169214-602FD486-E701-43C7-B1F7-EA7BC790B79AQ43169232-3EF362F0-9268-46B5-8F41-13693FAEAE58Q43169255-62428FF7-6DB3-4B6F-A563-EC881AF4620EQ43215477-2E09297E-ACFB-4847-9D9F-ACC45C01626BQ44604613-5DF0E9C0-9AD1-4C93-975B-BB703D2C2148Q45020148-223E486C-D770-4CE0-8B0B-BA3150EE4E9C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mark A Toleman
@ast
Mark A Toleman
@en
Mark A Toleman
@es
Mark A Toleman
@nl
type
label
Mark A Toleman
@ast
Mark A Toleman
@en
Mark A Toleman
@es
Mark A Toleman
@nl
prefLabel
Mark A Toleman
@ast
Mark A Toleman
@en
Mark A Toleman
@es
Mark A Toleman
@nl
P108
P106
P1153
6701351283
P31
P496
0000-0002-9497-0512